Grant Sean
CHIEF FINANCIAL OFFICER
Grant Sean has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Feb 25, 2026.
On the most recent filing, Grant Sean is listed as CHIEF FINANCIAL OFFICER at Vera Therapeutics, Inc. Inside the rolling window, Grant Sean reported no open-market purchases and 1 open-market sale totaling $208K in VERA.
Companies traded
Other insiders at VERA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$208K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Grant Sean made?
Grant Sean has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Grant Sean trade?
Grant Sean has filed SEC Form 4 disclosures for 1 company, including VERA.
When was Grant Sean's most recent SEC Form 4 filing?
Grant Sean's most recent SEC Form 4 filing on Tracefour is dated Feb 25, 2026.
What is Grant Sean's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Grant Sean is listed as CHIEF FINANCIAL OFFICER.
What is Grant Sean's total buy and sell value in the current window?
Inside the rolling retention window, Grant Sean bought $0 and sold $208K based on SEC Form 4 filings.
What was Grant Sean's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 4,949 VERA shares on 2026-02-23, worth $208K, per SEC Form 4 filings.